Related references
Note: Only part of the references are listed.An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
Soo Jeong Nam et al.
LEUKEMIA & LYMPHOMA (2014)
Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group
Naoki Wada et al.
HISTOPATHOLOGY (2012)
High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma
Qi-chun Cai et al.
MEDICAL ONCOLOGY (2012)
The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
Sofia Edin et al.
PLOS ONE (2012)
Tumor-Associated Macrophages in the Cutaneous SCC Microenvironment Are Heterogeneously Activated
Julia S. Pettersen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
Junliang Ma et al.
BMC CANCER (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis
Sverker Hasselblom et al.
PATHOLOGY INTERNATIONAL (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease
Xipeng Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Share Paper
